GT Biopharma (FRA:OXIA) Short Interest


FRA:OXIA GT Biopharma Inc FRA:OXIA
21 GF Score
Price €4.77
! 1 Warning Sign
View Full Analysis

What is GT Biopharma Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

FRA:OXIA vs CTXR, HIND, ZIVO: Short Interest Comparison

For the Biotechnology subindustry, GT Biopharma's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GT Biopharma Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, GT Biopharma's Short Interest distribution charts can be found below:

* The bar in red indicates where GT Biopharma's Short Interest falls into.


FRA:OXIA
21GF Score
GT Biopharma Inc FRA:OXIA
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

GT Biopharma Business Description

Other Exchanges GTBP:USA
Address 315 Montgomery Street, 10th Floor, San Francisco, CA, USA, 94104
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. The company is engaged in discovering, developing, and commercializing therapeutics from its proprietary product platform across various disease areas, mainly focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platform offers immuno-oncology products designed to treat hematologic malignancies, sarcoma, and solid tumors.
21GF Score

Get the complete analysis for FRA:OXIA

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.77
Price